BIO-RAD LABORATORIES, INC. — Director's Dealing 2022

Sep 7, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2022-09-02

Reporting Person: RAMALINGAM AJIT (SVP, Chief Accounting Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-09-02	Bio-Rad A Common Stock	M	241	—	Acquired	449.4969	Direct
2022-09-02	Bio-Rad A Common Stock	F	84	$478.32	Disposed	365.4969	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-09-02	Restricted Stock Units	$0	M	241	Disposed		Bio-Rad A Common Stock (241)	Direct

Footnotes

F1: Shares of Class A common stock acquired on the vesting of restricted stock units.

F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3: On September 2, 2020, the reporting person was granted 963 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.